Collin Shaw, Author at Buhlmann Diagnostics Corp

Rapid Worsening of IgM Anti-MAG Demyelinating Polyneuropathy During Rituximab Treatment

Anti-MAG Autoantibodies ELISA: Stork AC et al.; Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment. J Peripher Nerv Syst. 2013 Jun; 18(2):189-91. PMID:23781968. Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only. Not for use in diagnostic procedures in the US. Health Canada License: 89118

Acute Neurological Worsening After Rituximab Treatment in Patients with Anti-MAG Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Sala E et al.; Acute neurological worsening after Rituximab treatment in patients with anti-MAG neuropathy. J Neurol Sci. 2014 Oct 15; 345(1-2):224-7. PMID:25115501 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only. Not for use in diagnostic procedures in the US. Health Canada License: 89118

Prevalence, Specificity and Functionality of Anti-Ganglioside Antibodies in Neuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Prevalence, specificity and functionality of anti-ganglioside antibodies in Neuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol. 2014 Mar 15; 268(1-2): 89-94. PMID:24529728 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only. Not for use in diagnostic procedures in the US. Health Canada License: 89118

Polyneuropathy with Anti-sulfatide and Anti-MAG Antibodies: Clinical, Neurophysiological, Pathological Features and Response to Treatment

Anti-MAG Autoantibodies ELISA Citation: Campagnolo M et al.; Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment. J Neuroimmunol. 2015 Apr 15; 281:1-4. PMID:25867460 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only. Not for use in diagnostic procedures in the US. Health Canada License: 89118

Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies

Anti-MAG Autoantibodies ELISA Citation: Magy L et al.; Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies; J Immunol Res. 2015;2015: 450391. doi: 10.1155/2015/450391. Epub 2015 May 6. PMID:26065001 Anti-MAG Autoantibodies ELISA is for Research Use Only. Not for use in diagnostic procedures in the US. Health Canada License: 89118

Fcγ Receptor IIIA Genotype is Associated with Rituximab Response in Anti-Myelin-Associated Glycoprotein Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Fcγ receptor IIIA genotype is associated with rituximab response in anti-myelin-associated glycoprotein neuropathy. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8): 918-20.PMID:24487381 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only. Not for use in diagnostic procedures in the US. Health Canada License: 89118

Long-term Efficacy of Rituximab in IgM Anti-Myelin-Associated Glycoprotein Neuropathy: RIMAG Follow-up Study; Journal of the Peripheral Nervous System

Anti-MAG Autoantibodies ELISA Citation: Ferfoglia R I et al.; Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study; Journal of the Peripheral Nervous System 21:10–14 (2016)PMID:26748872 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only. Not for use in diagnostic procedures in the US. Health Canada License: 89118

Classical and Lectin Complement Pathway Activity in Polyneuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citations: Stork AC et al.; Classical and lectin complement pathway activity in polyneuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol. 2016 Jan 15; 290:76-9. PMID:26711574 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only. Not for use in diagnostic procedures in the US. Health Canada License: 89118

Anti-ganglioside Antibodies were not Detected in Human Subjects Infected with or Vaccinated Against 2009 Pandemic Influenza A (H1N1) Virus

Anti-GM1 Autoantibodies ELISA Citation: Lei T et al. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus. Vaccine. 2012 Mar 30; 30(16):2605-10.PMID:22342549 Highlight from this Publication "Anti-ganglioside antibodies, which might be associated with the development of GBS, were previously reported to be induced in mice

The Presence of Mycoplasma Pneumoniae Infection and GM1 Ganglioside Antibodies in Guillain-Barré Syndrome

BÜHLMANN GanglioCombi ELISA Citation: Sharma MB et al.: The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome. J Infect Dev Ctries. 2011 Jul 4; 5(6):459-64. PMID:21727645. Highlight from this Publication "Significant difference in levels of anti GM1 ganglioside antibodies (IgG & IgM) was seen between GBS patients and non-neurological controls, highlighting

Author: Collin Shaw

Rapid Worsening of IgM Anti-MAG Demyelinating Polyneuropathy During Rituximab Treatment

Acute Neurological Worsening After Rituximab Treatment in Patients with Anti-MAG Neuropathy

Prevalence, Specificity and Functionality of Anti-Ganglioside Antibodies in Neuropathy Associated with IgM Monoclonal Gammopathy

Polyneuropathy with Anti-sulfatide and Anti-MAG Antibodies: Clinical, Neurophysiological, Pathological Features and Response to Treatment

Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies

Fcγ Receptor IIIA Genotype is Associated with Rituximab Response in Anti-Myelin-Associated Glycoprotein Neuropathy

Long-term Efficacy of Rituximab in IgM Anti-Myelin-Associated Glycoprotein Neuropathy: RIMAG Follow-up Study; Journal of the Peripheral Nervous System

Classical and Lectin Complement Pathway Activity in Polyneuropathy Associated with IgM Monoclonal Gammopathy

Anti-ganglioside Antibodies were not Detected in Human Subjects Infected with or Vaccinated Against 2009 Pandemic Influenza A (H1N1) Virus

The Presence of Mycoplasma Pneumoniae Infection and GM1 Ganglioside Antibodies in Guillain-Barré Syndrome

ABOUT US

SOCIAL MEDIA

QUICK LINKS

CONTACT US